GlassScriptPhysician profile
Martha A Hickmann
NPI 1437147030
$8,354.63
in general payments reported to CMS, 2019-2025
30 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2020: $620 · 2021: $794 · 2022: $1,369 · 2023: $1,623 · 2024: $1,116 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,007 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,006.72 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,162.07 | 2019-2025 | |
| Janssen Biotech, INC. | $896.13 | 2020-2025 | Tremfya, Stelara, Simponi |
| Genzyme Corporation | $784.64 | 2019-2025 | |
| Galderma Laboratories, L.P. | $764.70 | 2019-2025 | Nemluvio, Dysport |
| Regeneron Healthcare Solutions, INC. | $684.82 | 2019-2025 | Libtayo, Dupixent |
| Amgen INC. | $563.15 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $502.63 | 2019-2024 | Olumiant, Taltz, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $476.25 | 2019-2024 | Siliq |
| Pfizer INC. | $284.46 | 2019-2025 | |
| Almirall LLC | $231.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $225.98 | 2019-2025 | |
| Incyte Corporation | $224.02 | 2022-2025 | Opzelura |
| Biofrontera INC. | $223.30 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Sun Pharmaceutical Industries INC. | $219.02 | 2020-2025 | Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $204.61 | 2022-2025 | Sotyktu |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $180.96 | 2022-2025 | Anzupgo |
| Allergan, INC. | $140.63 | 2019-2022 | |
| Prugen, INC. Pharmaceuticals | $123.27 | 2019-2020 | |
| Krystal Biotech INC | $97.42 | 2023-2025 | Vyjuvek |
| Astrazeneca Pharmaceuticals LP | $83.64 | 2024 | Airsupra |
| Genentech USA, INC. | $65.30 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $44.01 | 2019 | |
| Dermavant Sciences, INC. | $43.28 | 2024 | Vtama |
| Verrica Pharmaceuticals INC. | $34.36 | 2023-2024 | Ycanth |
| Vyne Pharmaceuticals INC. | $28.87 | 2020-2021 | |
| Ucb, INC. | $17.43 | 2019 | |
| Celgene Corporation | $12.28 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.17 | 2019 | |
| Merck Sharp & Dohme LLC | $11.97 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Hickmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.